ResearcherUniversity of Colorado AnschutzActive in the last 2 years
Hunter B. Moore
Matched on ORCID iD 0000-0002-5939-3828; OpenAlex author ID A5008748881. Sources: OpenAlex.
Their work
- Papers
- 2 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 8
2019: 1 paper · 2020: none · 2021: none · 2022: none · 2023: none · 2024: 1 paper
Papers 2
- Gaining a new angle on pancreas cancer: A pre-operative thrombelastographic parameter predicts recurrence and survival among patients with resected periampulla… First author DOI 10.1016/j.amjsurg.2024.115820↗
- The metabolic time line of pancreatic cancer: Opportunities to improve early detection of adenocarcinoma. Co-author DOI 10.1016/j.amjsurg.2019.08.015↗
Closest collaborators
The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Marco Del Chiaro · 2 shared papers, 2019–2024 · strength 0.30
- Paper Gaining a new angle on pancreas cancer: A pre-operative thrombelastographic parameter predicts recurrence and survival … DOI 10.1016/j.amjsurg.2024.115820↗
- Paper The metabolic time line of pancreatic cancer: Opportunities to improve early detection of adenocarcinoma. DOI 10.1016/j.amjsurg.2019.08.015↗
- Richard David Schulick · 2 shared papers, 2019–2024 · strength 0.30
- Paper Gaining a new angle on pancreas cancer: A pre-operative thrombelastographic parameter predicts recurrence and survival … DOI 10.1016/j.amjsurg.2024.115820↗
- Paper The metabolic time line of pancreatic cancer: Opportunities to improve early detection of adenocarcinoma. DOI 10.1016/j.amjsurg.2019.08.015↗
- Martin D. McCarter · 1 shared paper, 2024 · strength 0.21
- Alexander C. Schulick · 1 shared paper, 2024 · strength 0.21
- Ana Gleisner · 1 shared paper, 2024 · strength 0.21
- Barish H. Edil · 1 shared paper, 2024 · strength 0.21
- Angelo D’Alessandro · 1 shared paper, 2019 · strength 0.09
- Kirk Charles Hansen · 1 shared paper, 2019 · strength 0.09
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.